| Message: | Voriconazole Used for Potentially Life-Threatening Infection
Synonym: 2-(2, 4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1, 2, 4-triazol-1-yl)butan-2-ol; VORICONAZOLE; (2R, 3S/2S, 3R)-3-(5-FLUORO-4-PYRIMIDINYL)-2-(2, 4-DIFLUOROPHENYL)-1-(1H-1, 2, 4-TRIA; (aR, bS)-a-(2, 4-Difluorophenyl)-5-fluoro-b-methyl-a-(1H-1, 2, 4-triazol-1-ylmethyl)-4-pyrimidineethanol; UK-10949; Vorionazole; (2R, 3S)-2-(2, 4-DIFLUOROPHENYL)-3-(5-FLUOROPYRIMIDIN-4-YL)-1-(1H-1, 2, 4-TRIAZOL-1-YL)BUTAN-2-OL; (aR, S)-a-(2, 4-Difluorophenyl)-5-fluoro--methyl-a-(1H-1, 2, 4-triazol-1-ylmethyl)-4-pyrimidineethanol
CAS: 137234-62-9
MF: C16H14F3N5O
MW: 349.31
Assay: 99%
Appearance: White crystal Powder
Specification: CP
Property: Antifungal drugs, Broad spectrum antifungal
Usage: Voriconazole is a broad class of three azole antifungal agent, mainly used for potentially life-threatening infection in immunocompromised patients, treatment of. Indications include: Immunosuppressive severe fungal infection patients, acute invasive aspergillosis (the most common pathogenic bacteria and Aspergillus fumigatus, followed by Aspergillus flavus, Aspergillus Niger and Aspergillus terreus), severe invasive infection of Candida albicans resistant to fluconazole induced (including Candida krusei), serious infections caused by foot and Fusarium genera actinomycete bacteria. Moderate to severe renal insufficiency patients, careful after intravenous administration.
Package: 1kg/foil bag
|
my account
